Herbal Medicine Market Research Report by Product (Herbal Beauty Product, Herbal Dietary Supplement, and Herbal Functional Food), Form, Source, Type of Medicinal Plant, Indication, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19
New York, June 07, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Herbal Medicine Market Research Report by Product, Form, Source, Type of Medicinal Plant, Indication, Distribution Channel, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p06257475/?utm_source=GNW
The Global Herbal Medicine Market size was estimated at USD 108.19 billion in 2021 and expected to reach USD 116.25 billion in 2022, and is projected to grow at a CAGR 7.62% to reach USD 168.14 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across five major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Herbal Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Herbal Beauty Product, Herbal Dietary Supplement, Herbal Functional Food, and Herbal Pharmaceutical.
Based on Form, the market was studied across Capsules & Tablets, Extracts, Powders, and Syrups.
Based on Source, the market was studied across Barks Whole Plant, Fruit, Leaves, and Roots.
Based on Type of Medicinal Plant, the market was studied across Actaea Racemosa, Aloe Vera, Camellia Sinensis, Cinnamomum Spp, Cocos Nucifera, Curcuma Longa, Echinacea, Marrubium Vulgare, Vaccinium Macrocarpon, and Zingiber Officinale.
Based on Indication, the market was studied across Blood Disorders, Digestive Disorders, and Respiratory Disorders.
Based on Distribution Channel, the market was studied across E-Commerce, Hospital & Retail Pharmacies, and Specialty Pharmaceutical Stores & Labs.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.
This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Herbal Medicine market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Herbal Medicine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Herbal Medicine Market, including Arizona Natural Products, ARKOPHARMA Laboratories Company Ltd., Bayer AG, Beovita Vital GmbH, Bio-Botanica Inc., Blackmores Limited, Blue Sky Botanics Ltd., Dasherb Corp, Dr. Willmar Schwabe GmbH & Co. KG, Elzac Herbals, Frutarom Industries Ltd., Haldin Pacific Semesta, PT, Hishimo Pharmaceuticals Pvt. Ltd., Kalsec, Inc., Madaus GmbH, Prinova Group LLC., PT. Indesso Aroma, Ransom Naturals Ltd., Schaper & Brümmer GmbH & Co. KG, Synergy Flavors, Inc., Synthite Industries Ltd., TSUMURA & CO., Venus Pharma GmbH, Vopec Pharmaceuticals (P) Ltd., Weleda, and ZeinPharma Germany GmbH.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Herbal Medicine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Herbal Medicine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Herbal Medicine Market?
4. What is the competitive strategic window for opportunities in the Global Herbal Medicine Market?
5. What are the technology trends and regulatory frameworks in the Global Herbal Medicine Market?
6. What is the market share of the leading vendors in the Global Herbal Medicine Market?
7. What modes and strategic moves are considered suitable for entering the Global Herbal Medicine Market?
Read the full report: https://www.reportlinker.com/p06257475/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Not many hedge managers have ignited as much controversy as Cathie Wood. The founder of Ark Invest has built her brand on running against the crowd. From her early embrace of tech stocks to her outspoken political conservatism, Cathie Wood has always been something of a lightning rod. Whether her investments and stock strategies are panning out or not, one thing has always been consistent. Wood has never deviated from her path, and continues to this day to urge investors to stay the path. Wood h
Get in now before the train takes off?
Yahoo Finance Live anchors discuss fourth-quarter earnings for Palo Alto Networks as well as the company’s plans for a 3-for-1 stock split.
Warren Buffett likes to talk about buying more S&P 500 stocks when they're cheaper. But it turns out he's human, too.
Yahoo Finance Live looks at the meme stock market as Wedbush lowers its price target for AMC amid its APE shares debut.
The Boeing Co. could be leveraging its inventory of 737 MAX jets to work around ongoing delays from engine suppliers. According to a report from Leeham News — operated by veteran aerospace analyst Scott Hamilton — sources have indicated that Boeing (NYSE: BA) is developing plans to take engines from completed jets in storage and use them on newly built 737s with more immediate customers. Boeing and rival Airbus have felt the impact of engine delays from suppliers like CFM International and Pratt & Whitney for their competing narrow-body aircraft.
Berlin resists calls for full Russian energy embargo as chancellor’s popularity plummets
An increasingly popular consumer-facing operation is only part of the story for this challenger bank.
Yahoo Finance Live anchors discuss second-quarter earnings for Chinese EV maker XPeng.
JPMorgan Chase says ongoing inflation and an outlook for sharply lower returns for investors means that retirees should toss the long-standing 4% rule. That's the rule that says retirees can safely draw down their savings by 4% per year without … Continue reading → The post JPMorgan Says You Can Safely Withdraw This Much From Your Retirement Accounts Yearly appeared first on SmartAsset Blog.
It comes just a few days after the Gaithersburg biotech scored an emergency use authorization from the FDA.
A second-to-die policy is designed for couples who want to share a life insurance policy with specific beneficiaries, such as children and grandchildren. The life insurance company will only make a payout to the beneficiaries after the last survivor passes … Continue reading → The post Second-to-Die Insurance Policy Definition appeared first on SmartAsset Blog.
Yahoo Finance's Brian Cheung breaks down how meme stocks are trading on Tuesday.
Yahoo Finance's Alexis Keenan explains the allegations from a Twitter whistleblower on the tech company's security vulnerability and misleading statements, plus the latest from the trial between Elon Musk and Twitter.
The euro has dived to its lowest level against the dollar in 20 years, underlining the sense of foreboding in the 19 European countries that use it.
E-commerce stocks got a boost during the height of the pandemic, but since then many companies specializing in online sales and e-commerce platforms have tumbled. The most recent data shows that online sales make up just 14.5% of the total retail market in the U.S. right now, which leaves more opportunities for Shopify (NYSE: SHOP) and Amazon (NASDAQ: AMZN) to expand.
A $75-million superyacht linked to a sanctioned Russian steel billionaire was auctioned on Tuesday in Gibraltar, court sources said, in what is understood to be the first sale of its kind since Russia invaded Ukraine in February. The Axioma was impounded by the Gibraltar authorities in March after U.S. bank JP Morgan said its alleged owner Dmitry Pumpyansky had reneged on the terms of a $20 million loan. The 72.5-metre vessel was auctioned by the Gibraltar Admiralty Court through a system of closed bids to be sent electronically by midday on Tuesday, a court spokesman said.
An encouraging macro backdrop has accelerated the tailwinds for natural gas equities. In this context, companies like EQT, LNG and SBOW look particularly interesting.
ChargePoint Holdings, Inc. (CHPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Verve Therapeutics Inc (NASDAQ: VERV) announced new preclinical data supporting the nomination of the company's second product candidate, VERVE-201. VERVE-201 is designed to permanently turn off the ANGPTL3 gene in the liver, a key regulator of cholesterol and triglyceride metabolism. Verve is initially developing VERVE-201 for homozygous familial hypercholesterolemia (HoFH), a rare genetic subtype of atherosclerotic cardiovascular disease (ASCVD) characterized by extremely high blood low-densit
